Skip to content
Screener

Genpact G Cash & Equivalents

Cash & Equivalents at other companies

Innodata logo
InnodataINOD
$240.28M+302%
TTEC Holdings, Inc. logo
TTEC Holdings, Inc.TTEC
$88.75M+4.2%
Cognizant logo
CognizantCTSH
$1.04B-42.2%
ExlService Holdings logo
ExlService HoldingsEXLS
$146.77M-13.9%
Accenture logo
AccentureACN
$10.17B+5.5%
IBEX Limited logo
IBEX LimitedIBEX
$15.41M+18.7%

Other financials

Income statement

See full
Revenue$1.3B+7.1%
Gross profit$490.3M+8.9%
Operating income$192.9M+7.5%
Net income$145.7M+9.8%
EPS (diluted)$0.86+14.7%

Balance sheet

See full
Total debt$1.4B+21.6%
Total equity$2.6B+0.7%
Total assets$5.4B+2.0%

Cash flow

See full
Operating cash flow$72.4M-59.2%
CapEx$13.9M-37.3%
Free cash flow$58.5M-62.3%

Valuation

See full
Market cap$6.13B-16.9%
Enterprise value$7.02B-10.9%
P/E10.5×-3.2×
P/S1.2×-0.3×

Profitability

See full
Gross margin36.5%+0.8pp
Operating margin14.8%-0.1pp
Net margin11.1%+0.2pp
FCF margin10.9%-0.6pp

Returns & leverage

See full
Return on equity22.4%+0.6pp
Debt / equity0.5×+0.1×
Current ratio+0.5×

Where this comes from

Reported directly by Genpact in its filing.

Tagged under the XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue.

The source filing: Genpact’s 10-Q, filed August 7, 2026.

Filed
Aug 7, 2026, 10:51 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001398659-26-000014
Line itemNotesAs of June 30, 2026As of December 31, 2025
Assets
Current assets
Cash and cash equivalents$517,387$853,836
Short-term investments350,000
Accounts receivable, net of allowance for credit losses of $21,220 and $22,097 as of June 30, 2026 and December 31, 2025, respectively41,402,8151,240,550
Prepaid expenses and other current assets7250,552211,981
Total current assets$2,170,754$2,656,367
Property, plant and equipment, net8184,437190,448

Item 1. Unaudited Consolidated Financial Statements

FAQ

What is Genpact's cash & equivalents?
Genpact (G) reported cash & equivalents of $517.39M in Q2 2026.
How has Genpact's cash & equivalents changed year-over-year?
Genpact's cash & equivalents decreased by 22.0% year-over-year, from $663.26M to $517.39M.
What is the long-term trend for Genpact's cash & equivalents?
Over 5 years (2020 to 2025), Genpact's cash & equivalents has grown at a 4.6% compound annual growth rate (CAGR), from $680.44M to $853.84M.
What does cash & equivalents mean?
Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.

Ask your AI about Genpact's cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude